Christian Weyer, EVP, Research & Development at INTERCEPT PHARMACEUTICALS, INC. (ICPT), sold 6,228 shares at $100.00 ($623K) on 2019-11-25, disclosed to the SEC on 2019-11-27.
Open-market sale of $623k ICPT by EVP, Research & Development. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $100.00 | 1,855 | $186K | 29.8% |
| 2 | $100.00 | 4,373 | $437K | 70.2% |
| Total | $100.00 avg | 6,228 | $623K | 100% |
| Filing → |
| ICPT | SELL | 2020-01-27 | $136K | — | Filing → |
| ICPT | SELL | 2019-12-30 | $390K | — | Filing → |
| ICPT | SELL | 2019-12-02 | $106K | — | Filing → |